Atlas Trials

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

Clinical trial NCT07242248 · RECRUITING

Trial details

NCT number
NCT07242248
Sponsor
Janssen-Cilag Ltd.
Status
RECRUITING
Study type
OBSERVATIONAL
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
Start date
2025-11-17
Primary completion
2029-03-05
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.